FDA approves Merck's lung cancer drug as first-line treatment

(Reuters) - Merck & Co Inc on Monday said the U.S. Food and Drug Administration has approved its immunotherapy Keytruda for use in certain previously untreated lung cancer patients, making it the only approved first-line treatment.